Skip to main content
. Author manuscript; available in PMC: 2011 Oct 25.
Published in final edited form as: J Neuroimmune Pharmacol. 2010 Apr 17;5(3):404–417. doi: 10.1007/s11481-010-9203-1

Table 3.

Immune modulatory therapies associated with the development of progressive multifocal leukoencephalopathy

Drug name Alternative names Classification Target
Tysabri Natalizumab Monoclonal antibody α4-Chain of α4β1 integrin
Rituxan Rituximab Monoclonal antibody CD20
Raptiva Efalizumab Monoclonal antibody CD11a
Remicade Infliximab Monoclonal antibody Tumor necrosis factor α
CellCept Mycophenolate mofetil Small molecule prodrug Inosine monophosphate dehydrogenase